Board of Directors
Adam is an Operating Partner at Francisco Partners and the Chief Executive Officer of Landmark Health.
Prior to joining Francisco, Adam was Founder and CEO of aLabs, the nation’s largest provider of laboratory management services to health systems. Prior to taking his role at aLabs, Adam was a Principal at Accretive, LLC, where he was responsible for healthcare investments.
Prior to joining Accretive, Adam was Executive Vice President and General Manager at MedeFinance, the leading provider of healthcare analytics with over 600 hospital and insurance clients. Before MedeFinance, Adam was a venture capitalist with Battery Ventures.
As CEO of Echo Health Ventures, Rob leads the company's efforts to identify, invest in and grow innovative companies that enable and deliver a transformed experience to health care consumers nationwide. As part of Echo's unique collaboration with its founding partners, Rob works closely with the senior management teams and board of Cambia Health Solutions and Mosaic Health SolutionsMosaic Health Solutions to support strategic opportunities with Echo's portfolio companies, accelerate Cambia and Mosaic's strategies and more quickly bring meaningful health care innovation to national scale.
Rob has more than 20 years of experience in health care venture capital and business building. Before founding Echo, Rob served as the President of Cambia Health Solutions' diversified business unit (Direct Health Solutions). In this role, Rob oversaw Cambia's wholly-owned operating companies (including cost and quality transparency market leader HealthSparq and ancillary benefits provider LifeMap) as well as its venture and private equity investing activities. Rob joined Cambia in 2010 to launch and build the company's diversification and corporate venture investment efforts. Under Rob’s leadership, Cambia invested in nearly 20 health care technology companies.
In 2015, Rob cofounded the Cambia Grove - an innovation hub focused on catalyzing and supporting the Pacific Northwest’s emerging health care economic cluster. At the Cambia Grove, innovators and entrepreneurs work closely with regional stakeholders to find solutions to pressing health care challenges.
Before joining Cambia, Rob was the founding partner of Faultline Ventures, where he worked with numerous early stage companies and strategic investors. Previously, he was a Partner at Capitol Health Partners, a Washington, D.C., and New York City-based venture capital firm specializing in early-stage health services and health care information technology.
Active in industry and community organizations, Rob serves on the boards of several health care companies, including the most recent board seat for Avalon Healthcare Solutions and is a founder and former director of the Nashville-based largest network of young health care executives, Leadership Health Care. Rob also serves on the board of directors at Oregon Museum of Science and Industry (OMSI), the Cambia Health Foundation and is a member of the Health Executives Network (HELN) and Fellow of the American Leadership Forum. Rob previously served on the board of directors at Life Science Washington (formerly Washington Biotechnology & Biomedical Association).
Rob is a graduate of Georgetown University with a degree in history and is a Chartered Financial Analyst, charter holder.
Andy Folsom joined BlueCross BlueShield of South Carolina (BCBSSC) in Columbia, SC in 2009. He currently serves as AVP, Strategic Investments and M&A, and also as President of Companion Capital Management, Inc., a wholly owned subsidiary of BCBSSC. Prior to this role, Andy worked in the Law Department at BCBSSC as AVP and Deputy General Counsel. Before joining BCBSSC, Andy worked as a corporate transactional attorney at Alston & Bird in Atlanta, GA. Andy holds a BA from Washington and Lee University and a JD from the University of South Carolina School of Law.
In addition to his role at BCBSSC, Andy currently serves as a Board member at the Columbia Chamber of Commerce (Executive Committee member), United Way of the Midlands, Salute from the Shore (Chairman), Sisters of Charity Foundation of South Carolina (Executive Committee member), and Riverbanks Zoo Society (Executive Committee member).
Duncan James is an Operating Partner with Francisco Partners and focuses on the healthcare IT market.
Prior to Operating Partner role with Francisco Partners, Duncan was the CEO of two private-equity backed healthcare IT companies, MModal and QuadraMed. He also served as Group President at McKesson Corporation for 9 years responsible for the hospital and health systems market solutions and was a member of the McKesson Corporate Operating Committee. Duncan brings more than 25 years of experience in healthcare IT spanning domestic and international operations, strategic planning, sales and marketing, services, and product management.
Duncan serves on the Board of additional Francisco Partner companies including e-Solutions, Nextech, and QGenda. He received his Bachelor of Science degree in Industrial Management from the Georgia Institute of Technology.
Dr. Bill Kerr
Dr. Kerr joined Avalon as its Chief Executive Officer in 2013. In his role as Avalon’s Chief Executive Officer, Dr. Kerr provides leadership and direction to the executive management team and the company’s goal of improving access to affordable, high-quality health care services for members of regional and national health plans.
Dr. Kerr is a physician and former cancer researcher with more than 20 years of experience in building and leading innovative programs in health plans and specialty benefit management companies. Before joining Avalon Healthcare Solutions, Dr. Kerr was the Chief Medical and Growth Officer at CareCentrix, a company focused on health in the home.
Prior to CareCentrix, Dr. Kerr was the Chief Medical Officer at WellCare Health Plans and Blue Cross Blue Shield of Florida. Dr. Kerr was previously Vice President, Professional Networks at Independence Blue Cross and regional medical director for a number of plans in Texas.
Dr. Kerr holds a BA from the University of Arkansas, an MBA from the University of Houston, a MD from the University of Arkansas and was a research associate in the Nuffield department of pathology at the University of Oxford.
David H. Klein
David is a special advisor to the CEO of the University of Rochester (U of R) Medical Center, a professor of public health sciences in the U of R School of Medicine and Dentistry and an executive professor of health care management in the U of R William E. Simon Graduate School of Business (Simon School).
David was CEO of The Lifetime Healthcare Companies (TLHC) in Rochester, NY which includes Excellus BlueCross BlueShield, Univera Healthcare, Lifetime Health Medical Group, Lifetime Care, EBS-RMSCO Benefit Solutions and MedAmerica.
David serves as chair and director of the New York eHealth Collaborative overseeing the state’s Health Information Technology initiatives.
Alon is an Operating Advisor and Entrepreneur in Residence at Francisco Partners and focuses primarily on investments in the healthcare technology services sector. Prior to joining Francisco Partners in 2014, Alon was Co-Founder of Everspring, Inc., a company that provides full-service, customized online educational solutions.
Alon also spent several years as Vice President and Portfolio Co-Founder at Accretive, LLC. Accretive’s mission is to create specialized companies that deliver transformational value to customers. Alon served at the firm in increasing levels of responsibility from 2004 to 2011 and let the expansion effort of the firm into higher education.
Alon received his B.S. degree from University of California, Berkeley, where he graduated summa cum laude and his Masters of Business Administration from Stanford Graduate School of Business.
Ezra Perlman is a Partner at Francisco Partners and focuses primarily on investments in the software and services sectors, with a specific emphasis on healthcare technology.
Prior to joining Francisco Partners in 2003, Ezra was a venture capitalist with Battery Ventures, where he was involved in identifying, executing and managing private equity investments in software companies.
Ezra serves on the board of directors of Aesynt, API Healthcare, Healthland, Quantros, T-System and Therapeutic Research. He formerly served on the board of directors of Aconex, AdvancedMD, Attachmate, Attenti, Avangate, LYNX Medical Systems, RedPrairie, and SMART Modular.
Dr. Andrew Sekel
Dr. Sekel is a special advisor to Optum, where he previously served as CEO of specialty networks. As CEO, Dr. Sekel oversaw behavioral health, complex medical conditions, and physical health services, critical to improving the overall health and well-being of individuals in the employer and health plan markets, as well as beneficiaries in Medicaid, Medicare, and other local, state and federal programs.
Dr. Sekel has extensive experience in both the commercial and public sector health care markets. Prior to assuming his role with Optum, he was vice president of business development for the specialty division of Centene Corporation in St. Louis, MO.
Previously, he co-founded and led several behavioral health management companies in Texas and California, including Group Practice Affiliates, Integrated Mental Health, and Tejas Behavioral Health Services. As a leader of these companies, Dr. Sekel created integrated health care programs, processes and initiatives that provided the highest quality care for patients.
Dr. Sekel earned his Bachelor of Arts degree in psychology, Master of Education degree in special education and Doctor of Philosophy degree in counseling psychology from the University of Texas at Austin.